]> 2026-08-06T11:04:27+00:00 HDL 14 en 2013-09-24T05:49:32Z 2456559.7427315 HDL Heart protection study 0 en Heart protection study VA-HIT Trial 0 en VA-HIT Trial AIM-HIGH Trial 0 en AIM-HIGH Trial ARBITER 2 Trial 0 en ARBITER 2 Trial ARBITER 3 Trial 0 en ARBITER 3 Trial ARBITER 6-HALTS Trial 0 en ARBITER 6-HALTS Trial CLAS Trial 0 en CLAS Trial REGRESS Trial 0 en REGRESS Trial BECAIT Trial 0 en BECAIT Trial GAIN Trial 0 en GAIN Trial HARP Study 0 en HARP Study SCAT Trial 0 en SCAT Trial REVERSAL Trial 0 en REVERSAL Trial ASTEROID Trial 0 en ASTEROID Trial Oxford Niaspan Study 0 en Oxford Niaspan Study SATURN Trial 0 en SATURN Trial 4S Trial 0 en 4S Trial LIPID Study 0 en LIPID Study TNT Trial 0 en TNT Trial IDEAL Trial 0 en IDEAL Trial SEARCH Study 0 en SEARCH Study BIP Trial 0 en BIP Trial CARE Trial 0 en CARE Trial MEGA Trial 0 en MEGA Trial MIRACL Study 0 en MIRACL Study PROVE IT-TIMI 22 Trial 0 en PROVE IT-TIMI 22 Trial FLORIDA Trial 0 en FLORIDA Trial Phase Z of A-Z Trial 0 en Phase Z of A-Z Trial AFREGS Trial 0 en AFREGS Trial SPARCL Study 0 en SPARCL Study AVERT Trial 0 en AVERT Trial CORONA Trial 0 en CORONA Trial DEFINE Trial 0 en DEFINE Trial ILLUMINATE Trial 0 en ILLUMINATE Trial ILLUSTRATE Trial 0 en ILLUSTRATE Trial ACCELERATE Trial 0 en ACCELERATE Trial REVEAL Trial 0 en REVEAL Trial Clinical trial template 0 en Clinical trial template A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers 0 en A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers 0 en Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers Dal-VESSEL Trial 0 en Dal-VESSEL Trial Dal-PLAQUE Trial 0 en Dal-PLAQUE Trial The CHI SQUARE Trial 0 en The CHI SQUARE Trial A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients 0 en A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients THE ERASE TRIAL 0 en THE ERASE TRIAL Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes 0 en Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes HATS 0 en HATS RADIANCE 1 0 en RADIANCE 1 RADIANCE 2 0 en RADIANCE 2 REVEAL HPS-3 TIMI-55 trial 0 en REVEAL HPS-3 TIMI-55 trial Coronary drug project 0 en Coronary drug project Familial Atherosclerosis Treatment Study (FATS) 0 en Familial Atherosclerosis Treatment Study (FATS) Helsinki heart study 0 en Helsinki heart study FIELD study 0 en FIELD study Diabetes Atherosclerosis Intervention Study (DAIS) 0 en Diabetes Atherosclerosis Intervention Study (DAIS) UCSF-SCOR trial 0 en UCSF-SCOR trial Stockholm Ischemic Heart Disease Study 0 en Stockholm Ischemic Heart Disease Study 4S Trial 0 en 4S Trial A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers 0 en A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients 0 en A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients ACCELERATE Trial 0 en ACCELERATE Trial AFREGS Trial 0 en AFREGS Trial AIM-HIGH Trial 0 en AIM-HIGH Trial ARBITER 2 Trial 0 en ARBITER 2 Trial ARBITER 3 Trial 0 en ARBITER 3 Trial ARBITER 6-HALTS Trial 0 en ARBITER 6-HALTS Trial ASTEROID Trial 0 en ASTEROID Trial AVERT Trial 0 en AVERT Trial BECAIT Trial 0 en BECAIT Trial BIP Trial 0 en BIP Trial CARE Trial 0 en CARE Trial CLAS Trial 0 en CLAS Trial CORONA Trial 0 en CORONA Trial Clinical trial template 0 en Clinical trial template Coronary drug project 0 en Coronary drug project DEFINE Trial 0 en DEFINE Trial Dal-PLAQUE Trial 0 en Dal-PLAQUE Trial Dal-VESSEL Trial 0 en Dal-VESSEL Trial Diabetes Atherosclerosis Intervention Study (DAIS) 0 en Diabetes Atherosclerosis Intervention Study (DAIS) Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes 0 en Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes FIELD study 0 en FIELD study FLORIDA Trial 0 en FLORIDA Trial Familial Atherosclerosis Treatment Study (FATS) 0 en Familial Atherosclerosis Treatment Study (FATS) GAIN Trial 0 en GAIN Trial HARP Study 0 en HARP Study HATS 0 en HATS Heart protection study 0 en Heart protection study Helsinki heart study 0 en Helsinki heart study IDEAL Trial 0 en IDEAL Trial ILLUMINATE Trial 0 en ILLUMINATE Trial ILLUSTRATE Trial 0 en ILLUSTRATE Trial LIPID Study 0 en LIPID Study MEGA Trial 0 en MEGA Trial MIRACL Study 0 en MIRACL Study Oxford Niaspan Study 0 en Oxford Niaspan Study PROVE IT-TIMI 22 Trial 0 en PROVE IT-TIMI 22 Trial Phase Z of A-Z Trial 0 en Phase Z of A-Z Trial RADIANCE 1 0 en RADIANCE 1 RADIANCE 2 0 en RADIANCE 2 REGRESS Trial 0 en REGRESS Trial REVEAL HPS-3 TIMI-55 trial 0 en REVEAL HPS-3 TIMI-55 trial REVEAL Trial 0 en REVEAL Trial REVERSAL Trial 0 en REVERSAL Trial SATURN Trial 0 en SATURN Trial SCAT Trial 0 en SCAT Trial SEARCH Study 0 en SEARCH Study SPARCL Study 0 en SPARCL Study Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers 0 en Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers Stockholm Ischemic Heart Disease Study 0 en Stockholm Ischemic Heart Disease Study THE ERASE TRIAL 0 en THE ERASE TRIAL TNT Trial 0 en TNT Trial The CHI SQUARE Trial 0 en The CHI SQUARE Trial UCSF-SCOR trial 0 en UCSF-SCOR trial VA-HIT Trial 0 en VA-HIT Trial INST 102 en INST